Serum Osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Matsue, Yasuhiro ^a   Tsutsumi, Mikihiro ^a   Hayashi, Nobuhiko ^a   Saito, Takashi ^a   Tsuchishima, Mutsumi ^a   Toshikuni, Nobuyuki ^a   Arisawa, Tomiyasu ^a   George, Joseph ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 4; HYALURONIC ACID; OSTEOPONTIN; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT; AREA UNDER THE CURVE; BLOOD; CHRONIC HEPATITIS C; FEMALE; LIVER CIRRHOSIS; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VIROLOGY;

HEPATITIS C VIRUS;

AGED; AREA UNDER CURVE; BIOMARKERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OSTEOPONTIN; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84924565105     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118744     Document Type: Article

References (40)

1. George J, Chandrakasan G. Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim Biophys Acta 1996; 1292: 215-222. PMID: 8597566
2. George J, Rao KR, Stern R, Chandrakasan G. Dimethylnitrosamine-induced liver injury in rats: The early deposition of collagen. Toxicology 2001; 156: 129-138. PMID: 11164615
3. Bataller R, Brenner DA. Liver Fibrosis. J Clin Invest. 2005; 115: 209-218. PMID: 15690074
4. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275: 2247-2250. PMID: 10644669
5. Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011; 193: 225-231. doi: 10.1016/j.cbi.2011.07.001 PMID: 21803030
6. Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta 2006; 364: 33-60.PMID: 16139830
7. George J, Stern R. Serum hyaluronan and hyaluronidase: very early markers of toxic liver injury. Clin Chim Acta 2004; 348: 189-197. PMID: 15369754
8. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-8351. doi: 10.1016/S0140-6736(08) 60383-9 PMID: 18328931
9. Oldberg A, Franzen A, Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 1986; 83: 8819-8823. PMID: 3024151
10. Lund SA, Giachelli CM, Scatena M. The role of osteopontin in inflammatory processes. J Cell Commun Signal 2009; 3: 311-322. doi: 10.1007/s12079-009-0068-0 PMID: 19798593
11. Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int. 2011; 61: 265-280. doi: 10.1111/j.1440-1827.2011.02649.x PMID: 21501293
12. Mazzali M, Kipari T, Ophascharoensuk V, Wesson JA, Johnson R, Hughes J. Osteopontin-a molecule for all seasons. QJM 2002; 95: 3-13 PMID: 11834767
13. Urtasun R, Lopategi A, George J, Leung TM, Lu Y, et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling. Hepatology 2012; 55: 594-608. doi: 10.1002/hep.24701 PMID: 21953216
14. Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S. Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int. 2002; 52: 19-24. PMID: 11940202
15. Patouraux S, Bonnafous S, Voican CS, Anty R, Saint-Paul MC, et al. The osteopontin level in liver, adipose tissue and serum is correlated with fibrosis in patients with alcoholic liver disease. PLoS One 2012; 7: e35612. doi: 10.1371/journal.pone.0035612 PMID: 22530059
16. Bose SK, Ray R. Hepatitis C virus infection and insulin resistance. World J Diabetes 2014; 5: 52-58. doi: 10.4239/wjd.v5.i1.52 PMID: 24567801
17. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005; 5: 558-567. PMID: 16122679
18. Vezali E, Aghemo A, Colombo M. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin Ther. 2010; 32: 2117-2138. doi: 10.1016/S0149-2918(11)00022-1 PMID: 21316532
19. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010; 29: 437-445. doi: 10. 1111/j.1465-3362.2009.00153.x PMID: 20636661
20. Thorgeirsson SS, Grisham JW. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346. PMID: 12149612
21. Wong N, Lai P, Pang E, Fung LF, Sheng Z, et al. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res. 2000; 6: 4000-4009. PMID: 11051249
22. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520 PMID: 8188183
23. de Oliveria Andrade LJ, D'Oliveira A, Melo RC, De Souza EC, Costa Silva CA, Paraná R. Association between hepatitis C and hepatocellular carcinoma. J Glob Infect Dis. 2009; 1: 33-37 doi: 10.4103/ 0974-777X.52979 PMID: 20300384
24. Morales-Ibanez O, Domínguez M, Ki SH, Marcos M, Chaves JF, et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 2013; 58: 1742-1756. doi: 10.1002/hep.26521 PMID: 23729174
25. Misaki M, Shima T, Yano Y, Sumita Y, Kano U, et al. Basement membrane-related and type III procolla-gen-related antigens in serum of patients with chronic viral liver disease. Clin Chem. 1990; 36: 522-524. PMID: 2311224
26. Chichibu K, Matsuura T, Shichijo S, and Yokoyama MM. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 1989; 181: 317-323 PMID: 2474393
27. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biomet J. 2005; 47: 458-472.
28. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845.PMID: 3203132
29. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-802.
30. Nagoshi S. Osteopontin: Versatile modulator of liver diseases. Hepatol Res. 2014; 44: 22-30. doi: 10. 1111/hepr.12166 PMID: 23701387
31. Denhardt DT, Giachelli CM, Rittling SR. Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol. 2001; 41: 723-749. PMID: 11264474
32. Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013; 158: 807-820. doi: 10.7326/0003-4819-158-11-201306040-00005 PMID: 23732714
33. Arai M, Yokosuka O, Kanda T, Fukai K, Imazeki F, Muramatsu M, et al. Serum osteopontin levels in patients with acute liver dysfunction.Scand J Gastroenterol. 2006; 41: 102-110. PMID: 16373283
34. Lorena D, Darby IA, Gadeau AP, Leen LL, Rittling S, et al. Osteopontin expression in normal and fibrotic liver. Altered liver healing in osteopontin-deficient mice. J Hepatol. 2006 44: 383-390. PMID: 16221502
35. Lee SH, Seo GS, Park YN, Yoo TM, Sohn DH. Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem Pharmacol. 2004; 68: 2367-2378. PMID: 15548383
36. Zhou X, Murphy FR, Gehdu N, Zhang J, Iredale JP, Benyon RC. Engagement of avb3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem. 2004; 279: 23996-24006. PMID: 15044441
37. Huang W, Zhu G, Huang M, Lou G, Liu Y, Wang S. Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects. Clin Chim Acta 2010; 411: 675-678 doi: 10.1016/j.cca.2010.01.029 PMID: 20138033
38. Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, Sayed D. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Ann Hepatol. 2011; 10: 296-305. PMID: 21677331
39. Zhao L, Li T, Wang Y, Pan Y, Ning H, Hui X, et al. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection. Int J Clin Pract. 2008; 62: 1056-1062. PMID: 17537188
40. Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci. 2008; 103: 4-13. PMID: 17890765